AU4197389A - In vivo infection of live insects with a recombinant baculovirus - Google Patents

In vivo infection of live insects with a recombinant baculovirus

Info

Publication number
AU4197389A
AU4197389A AU41973/89A AU4197389A AU4197389A AU 4197389 A AU4197389 A AU 4197389A AU 41973/89 A AU41973/89 A AU 41973/89A AU 4197389 A AU4197389 A AU 4197389A AU 4197389 A AU4197389 A AU 4197389A
Authority
AU
Australia
Prior art keywords
recombinant baculovirus
live insects
vivo infection
infection
vivo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU41973/89A
Inventor
George Acs
Peter Price
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Icahn School of Medicine at Mount Sinai
Original Assignee
Mount Sinai School of Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mount Sinai School of Medicine filed Critical Mount Sinai School of Medicine
Publication of AU4197389A publication Critical patent/AU4197389A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14151—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU41973/89A 1988-08-05 1989-08-04 In vivo infection of live insects with a recombinant baculovirus Abandoned AU4197389A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22915788A 1988-08-05 1988-08-05
US229157 1988-08-05

Publications (1)

Publication Number Publication Date
AU4197389A true AU4197389A (en) 1990-03-05

Family

ID=22860048

Family Applications (1)

Application Number Title Priority Date Filing Date
AU41973/89A Abandoned AU4197389A (en) 1988-08-05 1989-08-04 In vivo infection of live insects with a recombinant baculovirus

Country Status (2)

Country Link
AU (1) AU4197389A (en)
WO (1) WO1990001556A1 (en)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2048646B1 (en) * 1992-04-15 1994-10-01 Ercros Sa PROCEDURE FOR THE OBTAINING OF AFRICAN EQUINE PLASTER VIRUS PROTEIN VP2 (AHSV)
DK0638124T3 (en) * 1992-04-29 2003-10-13 Thompson Boyce Plant Res Oral infection of insect larvae with pre-occluded baculovirus particles
US6090379A (en) * 1992-04-29 2000-07-18 Boyce Thompson Institute For Plant Research, Inc. Stable pre-occluded virus particle for use in recombinant protein production and pesticides
US5593669A (en) * 1992-04-29 1997-01-14 Boyce Thompson Institute For Plant Research, Inc. Stable pre-occluded virus particle
GB9924721D0 (en) 1999-10-19 1999-12-22 Craig Roger Protein production system
WO2001029204A2 (en) * 1999-10-19 2001-04-26 Minos Biosystems Limited Protein production system
WO2002006464A2 (en) * 2000-07-13 2002-01-24 The Curators Of The University Of Missouri Large scale expression and purification of recombinant proteins
RU2239443C2 (en) * 2002-05-27 2004-11-10 Пятигорская государственная фармацевтическая академия Drone larva homogenate and lyophilizate eliciting hypolipidemic and hepatoprotective activity
US8906676B2 (en) 2004-02-02 2014-12-09 Ambrx, Inc. Modified human four helical bundle polypeptides and their uses
WO2006069220A2 (en) 2004-12-22 2006-06-29 Ambrx, Inc. Modified human growth hormone
RU2258522C1 (en) * 2004-02-24 2005-08-20 Федеральное государственное образовательное учреждение высшего профессионального образования Ставропольский государственный аграрный университет Method for manufacturing a preparation for stimulating animal bodies out of drone bee larvae
AU2005265163B2 (en) 2004-06-18 2009-10-01 Ambrx, Inc. Novel antigen-binding polypeptides and their uses
WO2006091231A2 (en) 2004-07-21 2006-08-31 Ambrx, Inc. Biosynthetic polypeptides utilizing non-naturally encoded amino acids
SG158149A1 (en) 2004-12-22 2010-01-29 Ambrx Inc Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
CA2590429C (en) 2004-12-22 2014-10-07 Ambrx, Inc. Compositions of aminoacyl-trna synthetase and uses thereof
CN103290084A (en) 2004-12-22 2013-09-11 Ambrx公司 Method for expression and purification of recombinant human growth hormone
NZ555386A (en) 2004-12-22 2011-01-28 Ambrx Inc Formulations of human growth hormone comprising a non-naturally encoded amino acid
EP1893229B1 (en) 2005-06-03 2011-10-19 Ambrx, Inc. Improved human interferon molecules and their uses
WO2007021297A1 (en) 2005-08-18 2007-02-22 Ambrx, Inc. COMPOSITIONS OF tRNA AND USES THEREOF
WO2007059312A2 (en) 2005-11-16 2007-05-24 Ambrx, Inc. Methods and compositions comprising non-natural amino acids
CA2662753C (en) 2006-09-08 2016-02-23 Ambrx, Inc. Hybrid suppressor trna for vertebrate cells
JP5451390B2 (en) 2006-09-08 2014-03-26 アンブルックス，インコーポレイテッド Transcription of suppressor TRNA in vertebrate cells
EP2069396B1 (en) 2006-09-08 2015-10-21 Ambrx, Inc. Modified human plasma polypeptide or fc scaffolds and their uses
CN101121938B (en) * 2007-03-23 2010-10-06 中国农业科学院兰州兽医研究所 Method for preparing foot-and-mouth disease antigen
US8012931B2 (en) 2007-03-30 2011-09-06 Ambrx, Inc. Modified FGF-21 polypeptides and their uses
AU2008247815B2 (en) 2007-05-02 2012-09-06 Ambrx, Inc. Modified interferon beta polypeptides and their uses
MX338336B (en) 2007-11-20 2016-04-07 Ambrx Inc Modified insulin polypeptides and their uses.
EP2247743B1 (en) 2008-02-08 2016-04-06 Ambrx, Inc. Modified leptin polypeptides and their uses
ES2963062T3 (en) 2008-07-23 2024-03-25 Ambrx Inc Modified bovine G-CSF polypeptides and their uses
EA019653B1 (en) 2008-09-26 2014-05-30 Амбркс Инк. Modified animal erythropoietin polypeptides and their uses
TR201802361T4 (en) 2008-09-26 2018-03-21 Ambrx Inc Microorganisms and vaccines dependent on unnatural amino acid replication.
US20120283172A1 (en) 2009-12-21 2012-11-08 Ambrx, Inc. Modified porcine somatotropin polypeptides and their uses
CA2784793A1 (en) 2009-12-21 2011-07-21 Ambrx, Inc. Modified bovine somatotropin polypeptides and their uses
MX346786B (en) 2010-08-17 2017-03-31 Ambrx Inc Modified relaxin polypeptides and their uses.
US9567386B2 (en) 2010-08-17 2017-02-14 Ambrx, Inc. Therapeutic uses of modified relaxin polypeptides
TWI480288B (en) 2010-09-23 2015-04-11 Lilly Co Eli Formulations for bovine granulocyte colony stimulating factor and variants thereof
EP3909596A1 (en) 2014-10-24 2021-11-17 Bristol-Myers Squibb Company Modified fgf-21 polypeptides and uses thereof
MY193457A (en) 2017-02-08 2022-10-14 Bristol Myers Squibb Co Modified relaxin polypeptides comprising a pharmacokinetic enhancer and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0222412B1 (en) * 1985-11-14 1992-11-19 Daiichi Pharmaceutical Co., Ltd. Method of producing peptides
ES2008204A6 (en) * 1986-09-09 1989-07-16 Genetics Inst Method for producing a heterologous protein in insect cells.

Also Published As

Publication number Publication date
WO1990001556A1 (en) 1990-02-22

Similar Documents

Publication Publication Date Title
AU4197389A (en) In vivo infection of live insects with a recombinant baculovirus
AU1147988A (en) Improved disposable cup with an integrally formed straw
AU3026289A (en) Windrow merger
AU4088285A (en) A novel human physiologically active polypeptide
AU2084688A (en) Recombinant fibroblast growth factors
AU5615690A (en) Tines structure in clinical applicator
GB8828399D0 (en) Disposable covered needle assembly
AU2803392A (en) Disposable tissue retrieval assembly
NZ231803A (en) Transforming growth factor-beta2 and its preparation via recombinant techniques
AU7959187A (en) Insect repellant
AU3965089A (en) Plastic surgery implant
AU3228789A (en) Biologically active proteins
AU2886589A (en) A fabric treatment composition and the preparation thereof
AU3501889A (en) Fishing lure
AU2847389A (en) Single-use syringe
IL90690A0 (en) Tissue equivalents and their preparation
IL92359A0 (en) Zirconium oxide fibers and their preparation
AU5632090A (en) Fluorescent aquatic bioassay and procedure
AU3092989A (en) Illuminated fishing lure and battery therefor
GB8819541D0 (en) Insect repellent
GB8826104D0 (en) Phantom having similar optical characteristics to living tissue
AU4846090A (en) Single-use medical needle
AU5764290A (en) Recombinant avipoxvirus
AU1821788A (en) Stabilized aqueous biocide composition incorporating a polymer and phthalate
EP0450100A4 (en) Physiologically active peptide